Table: Kaken Pharmaceutical -Q1 group results

KAKEN PHARMACEUTICAL

07/08/2024 07:02

Aug 7 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             18.25               18.15            88.50    
                 (+0.6 pct)          (-0.3 pct)       (+22.8 pct) 
  Operating          2.75                3.29            20.80    
                 (-16.5 pct)         (-18.8 pct)     (+118.6 pct) 
  Recurring          3.01                3.49            21.20    
                 (-13.7 pct)         (-19.5 pct)     (+113.0 pct) 
  Net                1.75                2.51            14.20    
                 (-30.1 pct)         (-13.7 pct)      (+76.9 pct) 
  EPS             46.32 yen           66.99 yen       374.97 yen  
  Ann Div                            150.00 yen       190.00 yen  
  -Q2 div                             75.00 yen       115.00 yen  
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T